Transcutaneous laser for treatment of amputation neuromas

Swansea Bay University Health Board0 个研究点目标入组 10 人开始时间: 2022年8月30日最近更新: 2022年9月12日

试验速览

暂无简介。

•1. Adult patients (aged >18 years)
•2. Capable of giving informed consent
•3. Any Fitzpatrick skin type
•4. Have undergone amputation (any method) subsequently complicated by the development of reduction (stump) neuroma
•5. The patient is not eligible, or declines, further conventional treatment

•1. Photosensitising or photo-bio-modulating medications
•2. Patients on psoralens
•3. Patients suffering from any condition aggravated by near infra-red wavelengths
•4. Patients suffering from porphyria
•5. Patients on anticoagulants
•6. Any condition where laser is contraindicated
•7. Patients with overlying skin breaches or infection
•8. Patients on anticoagulants
•9. Patients with concomitant neurological conditions
•10. Patients with a known history of altered sensation (e.g. Charcot’s illness)
•11. Patients objecting to receiving treatment with laser
•12. Patients who are pregnant
•13. Patients who object to their GP being notified.
•14. Patients with no targetable nerve/s identified on ultrasound
•15. Patients where diagnostic injection of local anaesthetic fails to confirm a targetable nerve

发起方